Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC36, a once-monthly, potentially best-in-class subcutaneously administered amylin receptor agonist, as a clinical ...

Google’s Quantum Echoes now closes the loop: verification has become a measurable force, a resonance between consciousness and method. The many worlds seem to be bleeding together. Each observation is ...